Detalles de la búsqueda
1.
Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
Respir Res
; 22(1): 272, 2021 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34686204
2.
Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
JAMA
; 321(17): 1693-1701, 2019 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31063575
3.
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study.
Respir Med
; 218: 107393, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640273
4.
The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 µg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants.
Int J Chron Obstruct Pulmon Dis
; 18: 2725-2735, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046981
5.
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.
Int J Chron Obstruct Pulmon Dis
; 17: 1715-1733, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941901
6.
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.
Drugs R D
; 22(1): 35-42, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133636
7.
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.
Clin Drug Investig
; 42(4): 319-331, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290649
8.
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial.
Int J Chron Obstruct Pulmon Dis
; 16: 689-699, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33776428
9.
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.
Int J Chron Obstruct Pulmon Dis
; 16: 1461-1475, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103906
10.
Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial.
Adv Ther
; 38(10): 5381-5397, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34528220
11.
Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.
Chronic Obstr Pulm Dis
; 5(1): 5-15, 2018 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29629400
12.
Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia.
Am J Psychiatry
; 163(10): 1829-31, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17012697
Resultados
1 -
12
de 12
1
Próxima >
>>